eISSN: 2084-9850
ISSN: 1897-3116
Pielęgniarstwo Chirurgiczne i Angiologiczne/Surgical and Vascular Nursing
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
2/2024
vol. 18
 
Poleć ten artykuł:
Udostępnij:
Artykuł oryginalny

Acceptance of maggot wound therapy in a group of people with chronic wounds

Adrian Bazaliński
1
,
Karol Sieńczak
2, 3
,
Anna Kołodziej
4
,
Anna Nowak
5
,
Dariusz Bazaliński
2, 6

  1. Student, Medical Faculty, President Stanisław Wojciechowski University, Kalisz, Poland
  2. Podkarpackie Specialist Oncology Centre, Specialist Hospital, Brzozów, Poland
  3. Institute of Medicine, State University, Sanok, Poland
  4. University Teaching Hospital them. Frederic Chopin in Rzeszów, Rzeszów, Poland
  5. University of Rzeszow, Rzeszów, Poland
  6. Institute of Health Sciences, College of Medical Sciences, University of Rzeszów, Rzeszów, Poland
Pielęgniarstwo Chirurgiczne i Angiologiczne 2024; 18(2): 64–70
Data publikacji online: 2024/07/16
Plik artykułu:
Pobierz cytowanie
 
Metryki PlumX:
 

Introduction

Chronic wounds pose a major challenge to healthcare systems worldwide. In Europe, an estimated 1.5–2 mln people suffer from acute or chronic wounds [1]. Based on a systematic review by Martinengo et al., the incidence of wounds of vascular aetiology in the general population accounts for 1.51–2.21 per 1000 inhabitants [2]. One of the main problems related to the healing process that experts point to is the elimination of biofilm and increasing antibiotic resistance. A meta-analysis by Malone et al. confirmed the presence of biofilm in 78.2% of chronic wounds [3]. Excessive and unwarranted antibiotic therapy contributes to the development of a subpopulation of persister cells; thus, allowing the biofilm population to re-establish. Increasing bacterial resistance prolongs healing time, increasing the overall cost of patient care and society’s overall financial expenditure [4, 5]. Research by Sherman et al. on the elimination of bacterial flora, including methicillin-resistant Staphylococcus aureus, by larvae placed in the wound, has created new opportunities for wound debridement and microbial elimination for researchers and clinicians worldwide [6].
According to guidelines and recommendations, elimination of devitalised, necrotic tissue is a basic procedure in the treatment as well as management of the wound [7, 8]. The debridement of a wound in which regenerative processes are found to be inhibited is not subject to clear “rigid” guidelines. The method of eliminating non-physiological tissue is multifactorial and related to the area, location, and depth of the damaged structures, the amount of exudate, coexisting pain, and the patient’s general condition and preferences [9]. Mechanical (acute) wound debridement (rubbing, scraping, plucking, excising) is the simplest, cheapest, and fastest method of biofilm elimination performed by trained medical personnel [7, 10]. Nevertheless, in most chronic wounds with coexisting biofilm, more advanced preventive measures are required, as well as consideration of intervention in the form of bio-autolytic measures, followed by consideration of implementation of controlled negative pressure in local wound therapy [11, 12]. One of the methods of effective wound debridement is maggot debridement therapy (MDT) based on medical maggots. Currently, the larvae of the common green bottle fly, Lucilia sericata species, which feed only on necrotic tissues while keeping living tissues intact, are used in medicine [10, 13]. The eggs of the flies are sterilised several times, and the young broods are reared according to a strict protocol under aseptic conditions on sterile media before they reach the patient [6, 14]. The mechanism of MDT is based on 3 fundamental benefits that result from the larvae activity in the wound: bacteriostatic and bactericidal action (disinfection), mechanical debridement, and facilitation of the healing process [13, 15]. Maggot debridement therapy can be used in patients treated on an outpatient or inpatient basis. It is a simple, efficient, well-tolerated, and inexpensive way to treat hard-to-heal wounds in the debridement phase recommended the Polish Wound Management Association (PTLR) [10, 16]. Negative sensations and the sense of a foreign body can predispose to reluctance in the use of MDT. Patients often feel disgusted by the presence of living creatures in the wound. Larvae are associated with poor hygiene, dirt, and rotten food. A plausible explanation of the mechanism of action of maggots in the wound and pointing out the specific advantages of the therapy helps reduce negative thinking in the patient [17]. The authors report that most patients want to actively participate in the process of their treatment. Proper patient education will increase the patient’s sense of autonomy. The patient-nurse relationship is one of the main factors affecting the patient’s quality of life and acceptance of this form of therapy. The patient’s level of readiness and acceptance of therapy can be assessed by questionnaire methods [15, 18]. Recognition of health problems allows the planning of the actions of medical personnel, minimising negative psychosomatic effects. Emphasising health- -promoting behaviours and building the patient’s trust positively influence the willingness to implement innovative topical therapy. The purpose of this study was to assess the level of acceptance of MDT therapy, as well as selected variables potentially affecting acceptance of the method in a group of patients with chronic wounds.

Material and methods

The prospective study included 94 patients undergoing chronic wound management in non-residential care (long-term care, consultations as part of an ongoing statutory study at the University of Rzeszow in 2019–2020). Selection criteria were defined (informed consent, chronic wound 3/4° according to National Pressure Injury Advisory Panel (NPIAP), presence of necrotic tissue in the wound at least 50% according to colour classification: red, yellow, black (RYB), wounds located in the lower extremities and pelvic girdle, and pain not exceeding 4 points according to numerical rating scale (NRS). Patients whose pain intensity was more than 4% according to NRS, wounds in a location other than the pelvic girdle and lower extremities, atypical wounds, and wounds of neoplastic aetiology were excluded from the study. All patients were verbally instructed about the purpose of the study, gave written consent to participate in the study, completed a questionnaire evaluation, and signed a consent form for the application of maggots for wound debridement. Education on the principles of dressing application and observation was carried out for 10–15 min, each subject had the opportunity to contact the therapist by phone. The treatment protocol was based on the guidelines by the PTLR [10]. The protocol included keeping the maggots in the wound for 3 days (72 hours). A designated person with medical training who was licensed to treat wounds conducted supervision of the patient either in person or using teleinformation systems (WhatsApp, Messenger). Loose medical maggots by Biolab, Poland of 50–100 pieces were used in the therapy process.
A diagnostic survey method and estimation were used to construct the assumptions. The research tool was the proprietary questionnaire for collecting sociodemographic data and the Barthel scale assessing fitness [19]. The second part of the questionnaire was the wound assessment, in which a person qualified in wound prevention and treatment annotated the time of wound formation, location, depth of wound damage and area assessment based on the classification; RYB, NPIAP, WAGNER. A questionnaire developed by Bazalinski [20] was used to measure the MDT acceptance score. The tool consists of 10 questions, of which 2 general questions relate to coping with functioning with a chronic wound, while the remaining 8 questions relate to the patient’s feelings following chronic wound therapy with Lucilia sericata larvae. The subject scored answers to each question: 1 – strongly disagree, 2 – disagree, 3 – have no opinion, 4 – agree, 5 – strongly agree. The patient’s acceptance level score was determined based on 3 (low, average, high) levels of acceptance. Low level (10–30 points) means that the person does not accept this form of wound debridement and should not be qualified for MDT without physical and mental preparation. Medium level (31–40 pts) is characterised by the patient’s indecision to undertake MDT, the patient requires education and physical preparation. A high level (41–50 pts) is associated with full acceptance of the method, demonstrates familiarity with the method, and requires the provision of instruction on dressing application and control. The configuration of the questionnaire was designed to be applicable to assessing the degree of acceptance in MDT in any wound that meets the criteria of a difficult-to-heal and/or chronic wound. The questionnaire was methodologically tested on a sample of adults. The reliability of the scale is high, with an α-Cronbach coefficient of 0.83 [20].
The study was conducted by the wound care outpatient clinic of the Subcarpathian Oncology Centre in Brzozow in 2021 as a part of the statutory research conducted at the University of Rzeszow at the Institute of Health Sciences. The study protocol was approved by the Bioethics Commission at the University of Rzeszow (Resolution no. 30/06/2017, 30 June 2017). Moreover, the guidelines of the Helsinki Declaration were adhered to during the conducted study. Participants were informed about the purpose of the study and that they could withdraw at any point without giving a reason, and they provided informed consent before starting the study.
IBM SPSS v20 program was used to statistically process the collected material. Parametric and non-parametric tests were used to prepare the analysis of variables. The conformity of the distributions to the normal distribution was verified using the Kolmogorov-Smirnov test. The standard deviation (SD), median (Me), mean (M), maximum (Max), minimum (Min), lower quartile (Q1), and upper quartile (Q3) were calculated. The results obtained were presented in percentages. The Kruskal-Wallis H test was used to analyse the significance of differences in fitness across age categories. Friedman’s ANOVA analysis was used to verify the significance of differences in pain levels. After obtaining a statistically significant difference, an additional post hoc test was used. The Wilcoxon rank-sum sign test was used to assess significance. All analyses were performed assuming p < 0.05.
Characteristics of the respondents
The records of 94 subjects, including 58.5% (n = 55) men and 41.5% (n = 39) women, were submitted for statistical analysis. The youngest subject was 34 years old, the oldest 86. The average age was 70.09 ±13.12 years. The subjects mainly resided in rural areas 64.0% (n = 61), while 35.1% (n = 33) were urban dwellers (Tab. 1). The level of self-care among the subjects varied, with the greatest dysfunction presented by the elderly and those with pressure injuries. Full capacity was confirmed in 13.8% (n = 13), 67.0% (n = 63) showed limitations in self-care, and 19.1% (n = 18) were inefficient in self-care.

Results

Selected data on skin damage in the study sample
The time of wound formation varied, ranging 1.5–38 months. The wound area ranged 24–225 cm². The clinical evaluation recorded chronic wounds such as pressure injuries 31.9% (n = 30), mixed ulcers 22.3% (n = 21), venous ulcers 13.8% (n = 13), arterial ulcers 11.7% (n = 11), and other types of wound (infected surgical wounds, trauma) 20.2% (n = 19) (Tab. 2).
Based on RYB, the following were confirmed; yellow wounds 63.8% (n = 60), red-yellow wounds 25.5% (n = 24), and black wounds 8.5% (n = 8). Each of the qualified wounds covered full skin thickness (3° NPIAP) or penetrating to bone structures 4° NPIAP. Most of the qualified wounds were full-thickness skin lesions 61.7% (n = 58). Of all the subjects, 19.1% (n = 18) with foot wounds were graded according to the WAGNER scale (2–4°).
Acceptance of larval therapy in the study sample
The maggot debridement therapy Acceptance Questionnaire was used to assess acceptance of larval therapy. The scale takes values of 10–50 points. The mean value in the study sample was 41.2 points (41.2 ±4.6) (Tab. 3). The distribution of the MDT questionnaire measures can be considered normal based on the Kolmogorov-Smirnov test: D(94) = 0.088, p > 0.05.
On the basis of statistical analysis, the method used was evaluated by high, average, or low level of acceptance of MDT therapy. A medium (average) level of acceptance was noted in 41.5% of the subjects (n = 39), a high level of acceptance was noted in 57.4% (n = 54), and 1.1% (n = 1) had a low level of acceptance of the therapy. The data are shown in a histogram (Fig. 1).
Selected variables determining acceptance of maggot debridement therapy in the study sample
Gender
The variables of gender and level of acceptance were tabulated. The relationship was checked using the χ2 test. For this purpose, one case of low acceptance of therapy was eliminated from the analysis. The test confirmed that there was no relationship; χ2 (1) = 0.160, p = 0.689 (Tab. 4). It was confirmed that women and men show a similar level of acceptance of the therapy, and the hypothesis that gender determines the level of acceptance was rejected (p > 0.05).
It was assumed that the elderly have a low level of acceptance regarding the debridement of wounds by biological methods. The relationship was also checked using the χ2 test. For this purpose, one case of low acceptance of therapy was eliminated from the analysis. The test confirmed the lack of correlation; χ2 (3) = 3.334, p = 0.343 (Tab. 5). The hypothesis that age determines the level of acceptance was rejected (p > 0.05).
Type of wound
There was no confirmed relationship between variables like wound type and acceptance of MDT (χ2 (4) = 3.211, p = 0.523) (Tab. 6).
Wound area
In the analysis of the wound area and acceptance level, no statistical relationship was confirmed. The relationship was checked using the χ2 test (χ2 (3) = 3.188, p = 0.364) (Tab. 7). For this purpose, one case of low acceptance of therapy was eliminated from the analysis. The test confirmed the lack of correlation. The hypothesis that wound area determines the level of acceptance of therapy was rejected (p > 0.05).
Pain intensity
It was assumed that pain intensity (qualifying pain up to 4 points according to NRS) could determine the level of acceptance. The distribution of pain scores on the day of therapy is shown in Table 8. Five cases with missing data on pain intensity were excluded from the table. The variable does not have a normal distribution, as confirmed by the Kolmogorov-Smirnov test (D(98) = 0.231, p < 0.001).
The relationship was checked using the χ2 test. For this purpose, one case of low acceptance of therapy was eliminated from the analysis. The test confirmed the lack of correlation; χ2 (3) = 4.052, p = 0.256. Thus, the hypothesis of intensity as a factor affecting the level of acceptance of larval therapy was rejected (p > 0.05).
Time from wound onset
To test the relationship between the level of acceptance of MDT and the time of wound formation, the χ2 test was used. One case with a low level of acceptance and 3 cases with no information on the time of wound formation were eliminated from the analysis. The result of χ2 (4) = 12.431, p < 0.05, shows that there are grounds to conclude that there is a significant relationship between the variables. With increasing time from wound onset, the proportion of respondents declaring a high level of acceptance of this form of therapy increases significantly. A downward trend can be seen in those declaring a medium level of acceptance of MDT therapy. The category of respondents with a wound created 4–6 months before therapy stands out significantly. The correlation coefficient between variables, Kendall’s tau-c, amounts to 0.265, p < 0.05. The results are shown in Figure 2.

Discussion

This prospective study included 94 patients undergoing chronic wound care in ambulatory care. Most of the study group were male, i.e. 58.5% (female, 41.5%). The youngest person was 34 years old, while the oldest was 86 years old. The average age was 70.09 ±13.12 years. Eligible patients had a pain level of no more than 4 points according to NRS. Among the subjects, the time of wound formation ranged from 1.5 to 38 months. The wound area varied between 24 and 225 cm². The largest number of wounds with an aetiology of decubitus ulcers was recorded in 31.9% of the subjects. Based on the RYB, it was shown that more than half were yellow wounds: 63.8% (n = 60). Most of the eligible wounds were full-thickness skin lesions – 3º NPIAP 61.7% (n = 58). Respondents with foot wounds (diabetic foot disease wounds) were rated according to the WAGNER scale (2–4º) (19.1%, n = 18). The average acceptance of larval therapy in the study sample was 41.2 points (41.2 ±4.6). An average level of acceptance was recorded in 39 patients, while a high level of acceptance was declared by 54 patients, and only one patient had a low level of acceptance of the therapy. In the statistical analysis, the hypothesis of variables such as age, gender, and type and area of wound to determine the level of acceptance was rejected. However, it was noted that respondents who declared a long time of wound treatment clearly presented a higher level of acceptance compared to the rest of the group. The above observations indicate that people who deal with a wound that interferes with quality of life in certain areas over a long period of time are more open to non-conventional methods of local treatment. At the Subcarpathian Cancer Centre’s wound care clinic, larval therapy is a recommended and standard method of wound debridement for devitalised necrotic tissue, wounds infected with Pseudomonas aeruginosa, or Staphylococcus aureus, as well as to stimulate wound repair processes during healing. Each patient qualified for TLR is evaluated using the MDT questionnaire, signs a written consent form, and is mentally and physically prepared in terms of pain reduction. For more than 3 years of operation of the facility, it has been noted that each year the number of patients declaring themselves for local larval therapy increases. These observations are associated with satisfactory therapeutic effects. Unfortunately, certain factors interfere with the effectiveness of this form of therapy – somatic sensations and fear of maggots can reduce interest in the method [21]. In 2023 [16], the PTLR expert team prepared guidelines for the use of TLR in Poland; despite the practical indications, every effort should be made to strengthen the education and preparation of the patient for this form of therapy in the psychological as well as somatic aspects. Our observations clearly indicate that the intensity of pain increases during larval therapy, and similar observations are presented by other authors dealing with this issue [22–24].
Spilsbury et al. noted some correlation of acceptance of larval therapy relative to gender and age. Those who mainly would not consider TLR/MDT were older women. They related their concerns mainly to visual imagery [25]. In our study, we did not confirm such a relationship; however, opinions regarding disgust associated with the sight of creeping maggots are common among patients, regardless of gender and age. The use of maggot therapy in the process of chronic wound debridement is slowly becoming a standard method of management in outpatient and inpatient home settings, and it is recommended that further studies and observations be conducted and protocols be established related to the potential complications of the method to strengthen the scientific basis in terms of practical implications and to reduce patients’ fear of this form of therapy.

Conclusions

Acceptance of larval therapy in the study sample was at above average levels. Longer time from wound onset determines the high level of acceptance of this form of therapy. Variables such as age, gender, pain intensity, and type and area of wound have no effect on the level of acceptance of MDT. This was a single-centre study with a small sample of patients, so it is advisable to expand the study.

Disclosure

1. Institutional review board statement: Not applicable.
2. Assistance with the article: None.
3. Financial support and sponsorship: None.
4. Conflicts of interest: None.

References

1. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J 2016; 13: 5-15.
2. Martinengo L, Olsson M, Bajpai R, et al. Prevalence of chronic wounds in the general population: systematic review and meta- analysis of observational studies. Ann Epidemiol 2019; 29: 8-15.
3. Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care 2017; 26: 20-25.
4. Ciofu O, Rojo-Molinero E, Macia MD, et al. Antibiotic treatment of biofilm infections. APMIS 2017; 125: 304-319.
5. Akbas F, Ozaydin A, Polat E, Onaran I. Lucilia sericata larval secretions stimulating wound healing effects on rat dermal fibroblast cells. Rec Nat Prod 2020; 14: 340-354.
6. Sherman RA, Pechter EA. Maggottherapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis. Med Vet Entomol 1988; 2: 225-230.
7. Atkin L, Bućko Z, Conde Montero E, et al. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019; 28 (3 Suppl 3): 1-49.
8. Sibbald RG, Elliott JA, Persaud-Jaimangal R, et al. Wound bed preparation 2021. Adv Skin Wound Care 2021; 34: 183-195.
9. Bazaliński D, Przybek-Mita J, Lisowicz K, Skórka M, Więch P. Defensins of Lucilia sericata larvae and their influence on wound repair processes in practical assessment – a study of three cases. Int J Environ Res Public Health 2023; 20: 5357.
10. Szewczyk M, Cwajda-Białasik J, Mościcka P, et al. Treatment of pressure ulcers – recommendations of the Polish Wound Management Association. Part II. Leczenie Ran 2020; 17: 151-184.
11. Cwajda-Białasik J, Mościcka P, Szewczyk M. Selected methods of treatment of chronic wounds. Pielęg Chir Angiol 2019; 13: 1-11.
12. Hurlow JJ, Humphreys GJ, Bowling FL, et al. Diabetic foot infection: a critical complication. Int Wound J 2018; 15: 814-821.
13. Bazaliński D, Skórka M, Szymańska P, Wójcik A, Lipiński P. Lucilia sericata defensins and their capacity to stimulate wound regenerative processes. A review of the literature and our own observations. Leczenie Ran 2022; 19: 94-105
14. Wolff H, Hansson C. Rearing larvae of Lucilia sericata for chronic ulcer treatment – an improved method. Acta Derm Venereol 2005; 85: 126-131.
15. Sherman RA. Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here? Evid Based Complement Altern Med 2014; 2014: 592419.
16. Mrozikiewicz-Rakowska B, Tusiński M, Lipiński P, et al. Statement of the Polish Wound Management Association on larval therapy in wound management. Leczenie Ran 2023; 20: 89-95.
17. Bazaliński D, Przybek-Mita J, Pytlak K, et al. Larval wound therapy: possibilities and potential limitations – a literature review. J Clin Med 2023; 12: 6862.
18. Nigam Y, Williams S, Humphreys I, Clifford R, Brown A. An exploration of public perceptions and attitudes towards maggot therapy. J Wound Care 2022; 31: 756-770.
19. Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J 1965;14: 61-65.
20. Bazaliński D. Skuteczność terapii biologicznej z wykorzystaniem larw Lucilia sericata w leczeniu ran przewlekłych u chorych w opiece długoterminowej i paliatywnej. Uniwersytet Rzeszowski, Rzeszów, Poland 2019.
21. Morozov AM, Sherman RA. Survey of patients of the Tver region of Russia regarding maggots and maggot therapy. Int Wound J 2019; 16: 401-405.
22. Nigam Y, Williams S, Humphreys I, Clifford R, Brown A. An exploration of public perceptions and attitudes towards maggot therapy. J Wound Care 2022; 31: 756-770.
23. Mudge E, Price P, Walkley N, Harding KG. A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study. Wound Repair Regen 2014; 22: 43-51.
24. Mumcuoglu KY, Davidson E, Avidan A, Gilead L. Pain related to maggot debridement therapy. J Wound Care 2012; 21: 404-405.
25. Spilsbury K, Cullum N, Dumville J, et al. Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration. Health Expect 2008; 11: 148-159.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.